E. Neil Moore (eds.)
Showing all 5 results
-
Medicine
[PDF] Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 Robert B. Jennings M.D., Keith A. Reimer M.D., Ph.D. (auth.), Joel Morganroth, E. Neil Moore (eds.)
$9.99 Order now -
Medicine
[PDF] Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia: Proceedings of the Tenth Annual Symposium on New Drugs & Devices, October 31 ? November 1, 1989 William H. Frishman M.D. (auth.), Joel Morganroth, E. Neil Moore (eds.)
$9.99 Order now
![[PDF] Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984 E. Neil Moore D.V.M., Ph.D., Joseph F. Spear Ph.D. (auth.), Joel Morganroth, E. Neil Moore (eds.)](https://digzon.com/wp-content/uploads/2024/04/80b261a8f6448e9fb80540a50963b7e3-d.jpg)
![[PDF] Interventions in the Acute Phase of Myocardial Infarction Keith A. Reimer, Robert B. Jennings (auth.), Joel Morganroth, E. Neil Moore (eds.)](https://digzon.com/wp-content/uploads/2024/04/4be5cf9975541c0967295950ad97e994-d.jpg)
![[PDF] Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 Robert B. Jennings M.D., Keith A. Reimer M.D., Ph.D. (auth.), Joel Morganroth, E. Neil Moore (eds.)](https://digzon.com/wp-content/uploads/2024/04/0cfd1112f2166f496735f7d0041d0539-d.jpg)
![[PDF] Silent Myocardial Ischemia: Proceedings of the Symposium on New Drugs and Devices October 15?16, 1987, Philadelphia, Pennsylvania Peter F. Cohn (auth.), Joel Morganroth M.D., E. Neil Moore (eds.)](https://digzon.com/wp-content/uploads/2024/04/e6168520c0c0817eb033d04ab0588cc4-d.jpg)
![[PDF] Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia: Proceedings of the Tenth Annual Symposium on New Drugs & Devices, October 31 ? November 1, 1989 William H. Frishman M.D. (auth.), Joel Morganroth, E. Neil Moore (eds.)](https://digzon.com/wp-content/uploads/2024/04/a154b847de7b33e0475d3b8b28523868-d.jpg)